Chii chinonzi Lisocabtagene Maraleucel: Zvayakashandiswa, Mishonga, Migumisiro Yemuviri, nezvimwe

Lisocabtagene maraleucel mushonga wekenza unovhura nzira itsva unoshandisa maseru ako ekudzivirira chirwere kurwisa mamwe marudzi ekenza yeropa. Mushonga uyu wakagadzirirwa munhu mumwe nemumwe, unozivikanwawo seCAR-T cell therapy, unotora maT cells ako (rudzi rweropa jena), anochinjwa murabhoritari kuti azive zviri nani uye kurwisa maseru ekenza, wobva wadzoserwa mumuviri mako.

Kana iwe kana mumwe waunoda akakurudzirwa mushonga uyu, unogona kunge uine mibvunzo yakawanda nezvekuti unoshanda sei uye zvekutarisira. Nzira iyi itsva inomiririra tariro yevanhu vane mamwe ma lymphomas asina kupindura kune mamwe marapirwo, ichipa nzira itsva yekushandisa masisitimu ako ekudzivirira chirwere chekenza.

Chii chinonzi Lisocabtagene Maraleucel?

Lisocabtagene maraleucel imhando ye immunotherapy inonzi CAR-T cell therapy yakagadzirirwa kurapa mamwe marudzi ekenza yeropa. Mushonga uyu unogadzirwa zvakasiyana kune murwere mumwe nemumwe uchishandisa maseru avo ekudzivirira chirwere, ayo anounganidzwa, achichinjwa majini murabhoritari yakakosha, wobva wadzoserwa kuburikidza neIV infusion.

Mushonga uyu ndewemhando yemishonga inonzi "mishonga mhenyu" nekuti inosanganisira maseru mhenyu, akachinjwa anoenderera mberi achishanda mumuviri wako mushure me infusion. Maitiro acho anowanzo tora mavhiki akati wandei kubva panguva iyo maseru ako anounganidzwa kusvika wawana mushonga wekupedzisira, sezvo basa rerabhoritari richida kurongeka uye kutariswa kwemhando nekuchenjerera.

Kusiyana ne chemotherapy yechinyakare inokanganisa maseru ane hutano uye ekenza, mushonga uyu wakagadzirirwa kunangana nemaseru ekenza zvakananga uchichengetedza nyama yako yakajairika, ine hutano. Maseru akachinjwa akagadzirirwa kuziva protein inonzi CD19 iyo inowanzo kuwanikwa pamusoro pemamwe maseru e lymphoma.

Lisocabtagene Maraleucel inoshandiswa kuitei?

Lisocabtagene maraleucel inobvumidzwa kurapa vanhu vakuru vane mhando dzakasiyana dze large B-cell lymphoma dzakadzoka mushure mekurapwa kwapfuura kana dzisina kupindura kune nzira dzekurapa dzinenge mbiri dzakasiyana. Izvi zvinosanganisira diffuse large B-cell lymphoma, high-grade B-cell lymphoma, uye primary mediastinal large B-cell lymphoma.

Chiremba wako anowanzo kuraira kurapwa uku kana mamwe marapirwo akajairika asina kushanda zvakanaka kana kenza yadoka mushure mekutanga kupindura kurapwa. Inoonekwa seiyo vanachiremba vanoti

Mushure mekunge masero achinjwa uye akawanda murabhoritari, anotonhwa uye anotumirwa kudzokera kunzvimbo yako yekurapa. Paunogamuchira infusion, aya maT cells akawedzerwa anofamba mumuviri wako wese, achitsvaga uye achiparadza masero e lymphoma kwavanovawana. Masero akachinjwa anogona kuramba achishanda kwemwedzi kana kunyange makore mushure mekurapa kwekutanga.

Iyi inofungidzirwa semaitiro ekurapa akasimba zvishoma, akanyanya kuoma kupfuura akawanda marapirwo echinyakare asi anogona kupa mhinduro dzinogara kwenguva refu kuvanhu vane cancer dzisina kupindura kune mamwe marapirwo. Simba riri mukunyatsoita kwayo uye chokwadi chekuti inogadzira ndangariro yekusingaperi yekudzivirira immune pamusoro pekenza.

Ndingatora sei Lisocabtagene Maraleucel?

Lisocabtagene maraleucel inopiwa seimwe chete intravenous infusion munzvimbo yakakosha yekurapa cancer nevashandi vehutano vakadzidziswa. Hauzotore mushonga uyu kumba, uye maitiro ese anoda kubatana kwakanyatsoitwa pakati pako, chikwata chako chehutano, uye rabhoritari yakakosha inogadzirira masero ako.

Usati wagamuchira infusion, iwe unowanzoita conditioning chemotherapy regimen svondo rimwe chete usati wabatsira kugadzirira muviri wako maT cells akachinjwa. Pazuva re infusion, iwe uchagamuchira mushonga kuburikidza neIV line, uye infusion chaiyo inowanzo tora maminitsi makumi matatu kuti apedze.

Hauchazoda kudya kana kunwa chero chinhu chakakosha usati warapwa, asi chikwata chako chehutano chinogona kukupa mishonga yekubatsira kudzivirira mhedzisiro yakaita sefivha kana maitiro ekugumbuka. Iyo infusion inowanzoitwa munzvimbo yekunze, kunyangwe iwe uchizofanira kugara pedyo nenzvimbo yekurapa kwemavhiki akati wandei mushure mekuongorora pedyo.

Kupora kunosanganisira kugara mukati mehuwandu hwemamita kubva kunzvimbo yako yekurapwa kwemavhiki mana mushure mekuiswa, sezvo mativi emuviri anogona kukura mazuva kana mavhiki mushure mekurapwa. Chikwata chako chekuchengetwa kwehutano chichapa mirairo yakajeka pamusoro pezvirambidzo zvebasa, kana kutsvaga rubatsiro rwekurapa, uye zvirongwa zvekusangana zvekutevera.

Ndingatora Lisocabtagene Maraleucel kwenguva yakareba sei?

Lisocabtagene maraleucel inopiwa seimwe chete, imwe nguva yekuiswa panzvimbo yekurapa kuri kuenderera mberi kwaunotora kakawanda. Paunogamuchira kuisa, maseru eT akachinjwa anoenderera mberi achishanda mumuviri wako kwenguva yakareba, zvichigona kupa kudzora kenza kwenguva refu pasina kudiwa kwemadosi ekuwedzera.

Mhedzisiro yekurapa uku inogona kugara kwemwedzi kana makore, nevamwe vanhu vachiona kudzoserwa kwenguva refu kunoenderera mberi kwenguva refu mushure mekuiswa kwekutanga. Chikwata chako chekuchengetwa kwehutano chichatarisa mhinduro yako kuburikidza nemiedzo yeropa yenguva dzose, kuongorora mifananidzo, uye kuongorora kwemuviri kuti utarise kuti kurapwa kuri kushanda sei.

Nepo iwe usingagamuchiri madosi anowanzoitika emushonga wacho, iwe uchava nekuchengetwa kunoenderera mberi kunogona kuenderera mberi kwemakore mushure mekurapwa. Kuongorora uku kunobatsira kuona kuti kurapwa kunoenderera mberi kuchishanda nemazvo uye kunobvumira chikwata chako chekuchengetwa kwehutano kuti chigadzirise chero mhedzisiro yenguva refu kana matambudziko anogona kumuka.

Muzviitiko zvisingawanzoitiki apo kenza inodzoka mushure mekutanga mhinduro, chiremba wako angangokurukura kana iwe wakakodzera kurapwa kwechipiri kweCAR-T cell, kunyangwe izvi zvinoenderana nezvinhu zvakawanda zvemunhu uye hazvikurudzirwi otomatiki kune vese.

Ndezvipi Zvinhu Zvakaipa zveLisocabtagene Maraleucel?

Lisocabtagene maraleucel inogona kukonzera matambudziko akakomba, ayo akanyanya kukomba ari cytokine release syndrome (CRS) uye matambudziko emutsipa. CRS inoitika kana maseru ako akachinjwa eT ave akanyanya kushanda uye achibudisa zvinhu zvinogona kukonzera fivha, kudzikira kweropa, uye kuoma kufema, kazhinji zvichiitika mumazuva mashoma ekutanga mushure mekuiswa.

Kunzwisisa zvekutarisira kunogona kukubatsira iwe nemhuri yako kugadzirira rwendo rwekurapa rwuri mberi. Matambudziko mazhinji anogona kubatwa nekuchengetwa kwekurapa kwakakodzera, uye timu yako yehutano ichakutarisa zvakanyanya uye ichave nemishonga yakagadzirira kugadzirisa matambudziko sezvaanoitika.

Matambudziko akajairika ayo vanhu vazhinji vanowana anosanganisira:

• Fivha nekutonhora, kazhinji kutanga mukati memaawa ekuiswa
• Kuneta nekushaya simba zvinogona kutora mavhiki
• Kuderera kwemasero eropa, kuwedzera njodzi yekutapukirwa
• Nausea uye kudzikira kwechido
• Kutemwa nemusoro uye kurwadziwa kwemhasuru
• Kutsvukisa ganda kana kutsamwa
• Dhayareya uye kugumbuka mudumbu

Izvi zvinowanzoitika zvinowanzoitika kwenguva pfupi uye zvinovandudzika sezvo muviri wako uchigadzirisa kurapwa, kunyangwe nguva yacho ichisiyana kune munhu mumwe nemumwe.

Matambudziko akakomba anoda kutariswa kwekurapa nekukurumidza uye anosanganisira:

• Cytokine release syndrome ine fivha yakanyanya, kuneta kwakanyanya, uye kuoma kufema
• Matambudziko emutsipa senge kuvhiringidzika, kuoma kutaura, kana kubatwa nemoyo
• Kutapukirwa kwakanyanya nekuda kwekusadzivirirwa kwemuviri kwakaderera
• Kudzikira kweropa kunoda kupindira kwekurapa
• Tumor lysis syndrome kubva mukukurumidza kuparadzwa kweseru dzekenza

Timu yako yehutano ichakutarisa zvakanyanya matambudziko aya akakomba uye ine mishonga chaiyo iripo yekuvabata zvinobudirira kana zvikaitika.

Zvimwe zvisingawanzoitiki asi zvakakosha zvinogona kusanganisira:

• Kuverengwa kwemaseru eropa akaderera kwenguva yakareba, kunotora mwedzi
• Kenza dzekutanga, kunyangwe izvi zvisingawanzoitiki
• Kuneta kusingaperi kungaramba kwenguva yakareba
• Kukanganiswa kwekurangarira kana kufunga
• Kuwedzera kutapukirwa nezvimwe zvirwere

Nepo mhedzisiro iyi isingawanzoitiki ichiita seinotyisa, vanhu vazhinji vanoona kuti mabhenefiti anogona kuwanikwa ekuwana remission yekenza anopfuura njodzi idzi, kunyanya kana dzimwe nzira dzekurapa dzisina kubudirira.

Ndiani Asingafaniri Kutora Lisocabtagene Maraleucel?

Lisocabtagene maraleucel haina kukodzera munhu wese, uye timu yako yehutano ichanyatsoongorora kana iwe uri munhu akakodzera kurapwa uku. Vanhu vane zvirwere zvinoshanda, zvisingadzorwe vanowanzo fanira kumirira kusvikira chirwere charapwa vasati vaenderera mberi neCAR-T cell therapy.

Chiremba wako achaongorora zvinhu zvakati wandei kuti aone kana kurapwa uku kwakakodzera kwauri. Zvimwe zvirwere zvekurapa uye mamiriro anogona kuita kuti kurapwa uku kuve kwakanyanya njodzi kana kusava nemhedzisiro yakanaka mumamiriro ako chaiwo.

Mamiriro anogona kukutadzisa kugamuchira kurapwa uku anosanganisira:

• Zvirwere zvinoshanda, zvakakomba zvisina kupindura kurapwa
• Matambudziko akakomba emoyo, mapapu, kana chiropa anoganhurira kugona kwako kutsungirira kurapwa
• Zvimwe zvirwere zveautoimmune zvinoshanda kana zvisina kudzora zvakanaka
• Maitiro akakomba ekurwara kune chero zvinhu zvekushandisa kurapa
• Kuzvitakura kana kuyamwisa
• Mhando dzakasiyana dze lymphoma dzisingatauri iyo CD19 protein

Zvikonzero izvi hazvikubvise otomatiki, asi zvinoda kufunga zvakanyanya uye dzimwe nguva kumwe kuyedzwa kana kurapwa usati waenderera mberi.

Vashandi venyu vezveutano vachafungawo nezve hutano hwenyu hwese, rutsigiro rwemumba, uye kugona kugara pedyo nenzvimbo yekurapwa kuti muongororwe. Kuva nerutsigiro rwakakura kunokosha zvikuru sezvo muchada rubatsiro nemabasa ezuva nezuva panguva yekupora uye mumwe munhu wekutarisa zviratidzo zvinonetesa.

Zera rega harikubvise pakurapwa, asi vanhu vakuru vangatarisana nenjodzi dzinowedzera dzinoda kuyerwa pamwe chete nemabhenefiti anogona kuwanikwa. Chiremba wenyu achakurukura izvi zvinhu zvine njodzi nemi kuti akubatsire kuita sarudzo yakanakisisa yemamiriro enyu chaiwo.

Zita reBrand reLisocabtagene Maraleucel

Lisocabtagene maraleucel inotengeswa pasi pezita rebrand rekuti Breyanzi muUnited States nedzimwe nyika. Zita rebrand iri ndiro raunowanzoona pamapepa ako ekurapwa, kutaurirana kweinishuwarenzi, uye mapepa eruzivo rwemishonga.

Mishonga iyi inogadzirwa neBristol Myers Squibb, uye unogona kuona zvese zita re generic (lisocabtagene maraleucel) uye zita rebrand (Breyanzi) zvichishandiswa zvakatsinhaniswa mumarekodhi ako ekurapa. Mazita ese ari maviri anoreva kurapwa kumwe chete, saka usavhiringike kana ukaona mazwi akasiyana mumagwaro akasiyana.

Sezvo iyi iri kurapwa kwakakosha kunoda kugadzirwa kwetsika kumurwere wega wega, haisi kuwanikwa kuburikidza nemafemu enguva dzose semishonga yakajairika. Panzvimbo pezvo, inogoverwa kuburikidza nenetiweki yenzvimbo dzekurapa dzakavimbiswa dzine nzvimbo dzakakosha uye hunyanzvi hunodiwa kuti vashandise zvakachengeteka CAR-T cell therapy.

Lisocabtagene Maraleucel Zvimwe Zvingasarudzwa

Kurapa kwakawanda kwakasiyana kunovapo kune vanhu vane relapsed kana refractory hombe B-cell lymphoma, kunyangwe sarudzo yakanakisisa inoenderana nemamiriro ako chaiwo ekurapa uye kurapwa kwakapfuura. Mamwe marapirwo eCAR-T cell senge axicabtagene ciloleucel (Yescarta) uye tisagenlecleucel (Kymriah) anoshanda zvakafanana ne lisocabtagene maraleucel asi anogona kuva nemigumisiro yakasiyana.

Nzira dzekurapa dzechinyakare dzinosanganisira chemotherapy yakawanda inoteverwa nekuchinjiswa kwemasero emuti, izvo zvinogona kubatsira kune vamwe vanhu vane hutano hwakakwana kuti vashivirire nzira iyi yakanyanya. Kurapa kutsva kwakatarwa uye immunotherapies zviri zvakare kugadzirwa uye zvinogona kuwanikwa kuburikidza nekuedzwa kwekiriniki.

Vamwe vanhu vangafunga nezve chimeric antigen receptor natural killer (CAR-NK) cell therapy, iyo iri nzira yekurapa iri kubuda inoshandisa masero echisikigo killer panzvimbo peT cells. Zvisinei, kurapwa uku kuchiri kuyedzwa zvakanyanya uye kunowanikwa kunyanya kuburikidza nekudzidza kwetsvakurudzo.

Chikwata chako chehutano chichakurukura dzimwe nzira idzi zvichibva pamhando yako chaiyo ye lymphoma, hutano hwese, kurapwa kwakapfuura, uye zvaunofarira. Sarudzo inowanzo sanganisira kuyera mabhenefiti anogona kuitika pamusoro penjodzi uye mhedzisiro yega yega nzira.

Ko Lisocabtagene Maraleucel Zviri Nani Pane Axicabtagene Ciloleucel?

Ose ari maviri lisocabtagene maraleucel uye axicabtagene ciloleucel anobudirira CAR-T cell therapies yemhando dzakafanana dze lymphoma, asi vane misiyano mukuita kwavanogadzirwa uye mhedzisiro yavo. Lisocabtagene maraleucel inogona kukonzera cytokine release syndrome uye neurological side effects zvishoma kazhinji kupfuura axicabtagene ciloleucel, kunyangwe ese ari maviri kurapwa anogona kukonzera matambudziko aya.

Sarudzo pakati pekurapa uku inowanzoenderana nezvinhu zvakaita semitsetse yekugadzira, ruzivo rwe nzvimbo yako yekurapa nekurapa kwega kwega, uye njodzi dzako dzega. Dzimwe nzvimbo dzekurapa dzinogona kunge dzine ruzivo rwakawanda neimwe kurapa pane imwe, iyo inogona kukanganisa kurapwa.

Dheta rekuedza kwekurapa rinoratidza kuti kurapwa kwese kuri kuviri kune mwero wekubudirira wakafanana pakuwana remission, nemitengo yekupindura inowanzoita kubva pa60-80% muvanhu vane relapsed kana refractory large B-cell lymphoma. Kugara kwemhinduro kunoitawo sekunge kwakafanana pakati pekurapa uku kuviri, nevakawanda vachichengeta remission kwenguva yakareba.

Chikwata chako chekuchengetedzwa kwehutano chichafunga nezve nhoroondo yako chaiyo yezvokurapa, hunhu hwe lymphoma yako, uye zvinhu zvinoshanda sekufukidzwa kweinishuwarenzi uye kugona kwenzvimbo yekurapa kana ichikurudzira kuti ndeipi CAR-T cell therapy ingave yakanakira iwe. Hapana kurapwa kuno

Kupfuura muyero we lisocabtagene maraleucel hazviiti zvachose nekuti mushonga wega wega unogadzirirwa vanhu vese zvakasiyana uye unopiwa nevashandi vehutano vakadzidziswa muzvipatara zvakakosha. Mushonga uyu unopiwa kamwe chete, muyero wakatarwa zvichienderana nehuremu hwemuviri wako uye zvaunoda zvekurapa.

Kana uine zvaunonetseka nezve muyero wako kana kurapwa, taura navo nekukurumidza nechikwata chako chehutano. Vanogona kuongorora chirongwa chako chekurapa, kutsanangura maitiro ekuverenga muyero, uye kupindura chero mibvunzo yaungave uine nezvekuchengeteka uye kukodzera kwemuyero wako chaiwo.

Maitiro ekugadzira anosanganisira kuongororwa kwemhando dzakawanda kuti ave nechokwadi chekuti muyero chaiwo unogadzirirwa munhu wega wega, uye maitiro ekupa anosanganisira matanho ekuongorora kudzivirira kukanganisa kwemuyero. Chikwata chako chehutano chinotevera maitiro akasimba kuti uve nechokwadi chekuti unowana huwandu chaihwo hwemushonga.

Ndoita Sei Kana Ndikakundikana Kuwana Muyero we Lisocabtagene Maraleucel?

Kukundikana kuwana muyero we lisocabtagene maraleucel kazhinji hakusi dambudziko nekuti inopiwa se infusion imwe chete munzvimbo yekurapa inodzorwa panzvimbo yemushonga waunotora kumba. Kurapwa kwakarongeka zvakanyanya kwauri, uye chikwata chako chehutano chichave nechokwadi chekuti unowana infusion panguva yakakodzera.

Kana zvisingatarisirwi zvikakutadzisa kuwana infusion yako yakarongwa, senge kurwara kana emergency, chikwata chako chehutano chichashanda newe kuti urongezve kurapwa nekukurumidza sezvazvakachengeteka kuenderera mberi. Vanogona kuda kudzokorora mamwe bvunzo dzisati dzaitwa kana kugadzirisa chirongwa chako chemishonga yekugadzirisa.

Muzviitiko zvisingawanzoitiki uko maseru akagadzirwa asati akwanisa kuwana iwe, maitiro acho anogona kuda kudzokororwa, kutanga nekuunganidza maseru matsva. Chikwata chako chehutano chichakutungamira kuburikidza nechero zvigadziriso zvinodiwa kuchirongwa chako chekurapa uye kuve nechokwadi chekuti unowana kurapa paunenge wagadzirira.

Ndingamira Rini Kutora Lisocabtagene Maraleucel?

Hau"miri kutora" lisocabtagene maraleucel nenzira yechinyakare nekuti inopiwa se infusion imwe chete panzvimbo yemushonga unopfuurira. Paunogamuchira kurapwa, maseru eT akachinjwa anoramba achishanda mumuviri wako kwenguva yakareba, zvichikwanisa kupa kudzora kenza kwenguva refu.

Mhedzisiro yekurapwa inogona kugara kwemwedzi kana makore, uye hapana nzira yekuti "kudzima" maseru akachinjwa kana ari muhurongwa hwako. Iri ndiro rimwe remabhenefiti eCAR-T cell therapy, sezvo ichikwanisa kupa remissions dzinoshamisa pasina kudiwa kwekudzokorora kurapwa.

Kutarisirwa kwako kuchapfuurira kwenguva refu mushure mekurapwa kwekutanga, nekutarisa nguva dzose kuti uongorore kuti kurapwa kuri kushanda sei uye kuti utarise chero mhedzisiro yenguva refu. Kutarisirwa uku kunokosha pakuchengetedza hutano hwako uye kubata chero matambudziko angangovepo pakutanga.

Ndingafamba Here Mushure meKugamuchira Lisocabtagene Maraleucel?

Kufamba kunorambidzwa kwemavhiki mana mushure mekuwana lisocabtagene maraleucel nekuti mhedzisiro yakakomba inogona kukura panguva ino uye inoda kutariswa kwekurapa nekukasira kubva kuchikwata chako chekurapa. Unozofanira kugara mukati meimwe nzvimbo yenzvimbo yako yekurapa, kazhinji mukati memaawa maviri ekufamba.

Mushure menguva yekutanga yekutarisa, zvirambidzo zvekufamba zvinowanzo kusimudzwa, asi unofanira kugara uchizivisa chikwata chako chehutano nezve zvirongwa zvako zvekufamba. Vanogona kukupa ruzivo rwekurapa rwekugovana nevapi vehutano kana iwe uchida kutariswa kwekurapa uri kure nenzvimbo yako yekurapa.

Kufamba kwenguva refu kana kwenyika dzese kunogona kuda kuronga kwakawanda, kusanganisira kuona kuti une mukana wekutarisirwa kwekurapa kwakakodzera uye kutakura zvinyorwa nezvekurapwa kwako. Chikwata chako chehutano chinogona kukubatsira kuronga kufamba kwakachengeteka uye kukupa gwara pamatanho ekutora uri kure nemba.